Abstract:Epidermal growth factor receptor (EGFR) is known to be overexpressed in ~30% of gastric cancer (GC) cases, and may serve as an effective biomarker for predicting the clinical benefit of anti-EGFR therapy. However, the mechanism underlying the regulation of EGFR expression remains unknown. Evidence indicates that post-transcriptional regulation may exist in the process of EGFR expression. In the present study, we aimed to explore whether miR-370 is involved in this process, and how it impacts the biological behaviors of GC cells. In the present study, we first determined the role of EGFR in GC by means of an EGFR overexpression plasmid and siRNAs. Then, the expression levels of EGFR protein and mRNA in GC tissues were analyzed through immunohistochemistry and quantitative RT-PCR (RT-qPCR). Bioinformatics tools and dual-luciferase assay were applied to predict and validate the relevant miRNA targeting EGFR. Finally, human GC MGC-803 cells were selected to explore the effect of miRNA on cell proliferation and migration. We found that suppression of EGFR inhibited the proliferation and migration of GC cells. In addition, the levels of EGFR protein in the GC tissues were ~4 times higher than that in the corresponding paired non-cancerous tissues while the mRNA levels of EGFR were only ~2-fold as high as that in the adjacent non-cancerous tissues. Bioinformatics tools predicted that miRNA-370 was a regulator of EGFR and dual‑luciferase assay validated that miR-370 could directly bind to the 3'-untranslated region (3'-UTR) of EGFR mRNA. Meanwhile, an inverse correlation between miR-370 and EGFR was found in the GC tissues. Overexpression of miR-370 suppressed the proliferation and migration of GC cells, while downregulation of miR-370 promoted proliferation and migration. The present study may provide new information for understanding the molecular mechanism underlying the regulation of EGFR protein expression in GC and may be of important clinical significance to guide targeted therapy.

Mir-375 Inhibits the Proliferation of Gastric Cancer Cells by Repressing ERBB2 Expression.

MiR-375 Frequently Downregulated in Gastric Cancer Inhibits Cell Proliferation by Targeting JAK2

Restoration Of Mir-1228*Expression Suppresses Epithelial-Mesenchymal Transition In Gastric Cancer

Up-regulation of Microrna-375 Inhibits the Proliferation of Gastric Cancer Cell Through Targeting AEG-1.

Mir-129-5p Attenuates Cell Proliferation and Epithelial Mesenchymal Transition Via HMGB1 in Gastric Cancer

Mir-455 Inhibits Cell Proliferation and Migration Via Negative Regulation of EGFR in Human Gastric Cancer.

Hsa-Mir-376c-3p Regulates Gastric Tumor Growth Both in Vitro and in Vivo

Mir-370 Regulates Cell Proliferation and Migration by Targeting Egfr in Gastric Cancer

Mir-4677-3p Participates Proliferation and Metastases of Gastric Cancer Cell Via CEMIP-PI3K/AKT Signaling Pathway.

Mir-373 Suppresses Gastric Cancer Metastasis by Downregulating Vimentin.

Mirna-331-3p Directly Targets E2F1 and Induces Growth Arrest in Human Gastric Cancer.

Mir-375 Inhibits the Invasion and Metastasis of Colorectal Cancer Via Targeting SP1 and Regulating EMT-associated Genes.

The Up-Regulation of Mir-300 in Gastric Cancer and Its Effects on Cells Malignancy.

Mirna-381-3p Functions As a Tumor Suppressor to Inhibit Gastric Cancer by Targeting Fibroblast Growth Factor Receptor-2

MicroRNA Library-Based Functional Screening Identified Mir-137 As a Suppresser of Gastric Cancer Cell Proliferation

MiR-181d Inhibits Cell Proliferation and Metastasis Through PI3K/AKT Pathway in Gastric Cancer.

Microrna-375 Inhibits Colorectal Cancer Cells Proliferation by Downregulating JAK2/STAT3 and MAP3K8/ERK Signaling Pathways.

MicroRNA‐936/ERBB4/Akt axis exhibits anticancer properties of gastric cancer through inhibition of cell proliferation, migration, and invasion

Mirna-451 Inhibits Proliferation and Motility of the Gastric Cancer SGC-7901 Cell Line Via Targeting AKT-mediated Signal Pathway

Mir-1273H-5p Suppresses the Penetration and Pervasion of Gastric Cancer Cells Via Suppressing CXCL12 Expression

Mir-638 Suppresses Cell Proliferation in Gastric Cancer by Targeting Sp2.